Peeples Cancer Institute at Hamilton Medical Center has expanded access to the latest in cancer research for patients in ...

Researchers at the University of Tsukuba have investigated the changes in the primary evaluation items in phase II clinical ...

MacroGenics stated that although it has dropped vobra duo, it remains optimistic about its other candidate MGC026.

Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...

Founded in 1998 by Neal Shore, MD, FACS, CURC has conducted nearly 500 clinical trials, making it the top urologic oncology site worldwide by both volume and quality. With deep expertise in early ...

The FDA granted orphan drug designation to HLX22 for gastric cancer, advancing global phase 3 trials to improve first-line ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States and a ...

The FDA has granted approval to an act of compassionate use treatment with the anti-cancer drug Namodenoson for a patient ...

City of Hope has launched a phase 1/2 clinical trial to investigate whether denosumab, an FDA approved medication for the treatment of osteoporosis and bone tumors, can protect and regenerate beta ...

Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer ...